Herein, we report that high HE4 serum levels prior to TAVI are independently associated with higher rates of treatment futility, rehospitalization for HF, all-cause mortality, and are also associated with diffuse myocardial fibrosis. This evidence concerns the gene WFDC2 and hydrops fetalis.